Table 2.
Infinium sensitivity and specificity
| |
Sensitivity |
|||
|---|---|---|---|---|
| Deletion | Loss | Gain | Amplification | |
| Chondrosarcoma |
0.83 |
0.91 |
0.89 |
0.69 |
| GBM |
0.97 |
0.85 |
0.87 |
0.75 |
| Bladder cancer |
0.62 |
0.81 |
0.79 |
0.67 |
| Prostate cancer | 0.6 | 0.81 | 0.85 | 0.63 |
The sensitivity and specificity of CNAs identified between SNP array and Infinium methylation arrays for four tumor types across a range of alteration types.